RE:BTI:TSXV; BIOAF:OTCQB - Dr. Jeffrey Sprouse Appointment"to directors and officers of the Company and an investor relations consultant. All of the options expire five years from the date of the grant and are governed by the terms of the company’s stock option plan. The options are being issued as part of annual remuneration in lieu of cash compensation as the company prioritizes investment in partnership enhancing R&D."
so...no more salaries??
...well i hope all of your options end up in the money...